Live feed
Filing
SC 13G/A
SC 13G/A0001193125-18-186771·Dova Pharmaceuticals Inc.
Schedule 13G ownership disclosure
DOVA PHARMACEUTICALS INC
Security class unavailable · CUSIP: 25985T102
Event date: 2018-06-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-186771
- Form type
- SC 13G/A
- Filer
- Dova Pharmaceuticals Inc.
- CIK
- CIK 1685071
- Filed
- Jun 07, 2018
- Reporting period
- Jun 04, 2018
- Description
- Schedule 13G beneficial ownership